Scientists at Queen’s University Belfast have discovered a new molecule which has the potential to prolong the life of individuals with cystic fibrosis (CF).
The molecule represents a possible future treatment and works by altering cellular ion channels resulting in improved airway hydration and significantly increased mucus clearance.
For individuals with CF, normal airway clearance mechanisms which keep the lungs free of infection are defective. As a result, a build-up of mucus occurs and predisposes the individual to chronic bacterial infection. The ensuing cycles of chronic infection and airway inflammation cause progressive destruction of the airways, which is ultimately fatal.
The innovative approach could reduce the frequency of these infections through a novel protease inhibitor which prevents activation of the epithelial sodium channel; ENaC.
The research involved a team of scientists from Queen’s University alongside colleagues at the Royal College of Surgeons in Ireland and the University of North Carolina, and was funded by The Cystic Fibrosis Trust.
Speaking about the breakthrough, Dr Lorraine Martin from the School of Pharmacy at Queen’s University Belfast, said: “This is an important finding which could provide a novel therapeutic opportunity relevant to all individuals with CF, as the targeting of ENaC is independent of their underlying CF mutation. This strategy could prevent the significant lung damage that results from chronic cycles of infection and inflammation, with potential impact on quality of life as well as life expectancy. This is a further example of Queen’s University’s research advancing knowledge and changing lives.”
Ed Owen, Chief Executive at the Cystic Fibrosis Trust, said: “We are thrilled with these initial findings and are excited to see how the next stage of preclinical testing progresses. We are pleased to have been able to fund this world class project at its early stage and welcome the drug development programme planned over the coming years. Research is the biggest single area of investment for the Cystic Fibrosis Trust and it’s wonderful to see projects like this making such positive progress in our fight for a life unlimited.”
Currently available pharmacological alternatives are only suitable for a small subset of patients depending on the disease-causing genetic mutation.
The Latest on: Cystic Fibrosis
via Google News
The Latest on: Cystic Fibrosis
- Cystic fibrosis survivor wins Gordon Chesterman scholarship on February 19, 2019 at 2:00 pm
A cystic fibrosis survivor with a passion for Information Technology is the Wintec Gordon Chesterman scholarship recipient for 2018. Damien Bell, a second year Wintec student studying a Bachelor of In... […]
- Reading Hospital, Drexel College of Medicine launch Cystic Fibrosis clinic on February 19, 2019 at 11:56 am
Reading Hospital Tower Health and Drexel University College of Medicine announced recently they will collaborate on a cystic fibrosis clinic to be based in West Reading. Dr. Cecilia Smith, chairwoman ... […]
- 'Hunting Ground' Directors to Make Film Based on Memoir of Cystic Fibrosis Victim (Exclusive) on February 19, 2019 at 9:49 am
Kirby Dick and Amy Ziering will begin filming the untitled documentary this week that chronicles the of life Mallory Smith, who died in November 2017, two months after receiving a double-lung transpla... […]
- Cystic Fibrosis scandal: UK waits for wonder drug to save children's lives on February 19, 2019 at 9:37 am
Starting at 6.30am, Charlotte Taylor, three, has a relentless routine of pills, therapies, physiotherapy and diet-specific meals - and she is deemed one of the UK's healthier CF youngsters. Currently, ... […]
- Ivy's fight for Orkambi drug to treat Cystic Fibrosis on February 19, 2019 at 7:51 am
A mother and daughter from Portsmouth are asking people to take part in a challenge to raise awareness of Cystic Fibrosis. Five-year-old Ivy Weir has the condition and her mother Gemma has started a p... […]
- Directors of cystic fibrosis drug firm in NHS standoff made £15m on February 19, 2019 at 4:54 am
Vertex’s headquarters in Boston, Massachusetts. Photograph: Brian Snyder/Reuters Two UK directors of Vertex Pharmaceuticals, the company in a standoff with the NHS over the high price of its breakthro... […]
- Merrylands family rally to raise awareness and funds for cystic fibrosis on February 18, 2019 at 7:00 pm
We had never heard of cystic fibrosis 4½ years ago, yet it’s a genetic condition that my husband and I had unknowingly passed on to our little boy. Simon was diagnosed with cystic fibrosis at the age ... […]
- Cystic fibrosis drug scandal: Here's why we need the wonder drug right now on February 16, 2019 at 5:01 am
Senna van Engelen, who receives the drug free through her country's health service, is one of hundreds of children whose lives have been transformed since Orkambi was licensed in the Netherlands in 20... […]
- Jared Wells Has Cystic Fibrosis. Bodybuilding Changed His Life. on February 15, 2019 at 10:07 am
A longer version of this story appeared on the podcast Endless Thread. Jared Wells is originally from Utica, New York. And he recently started training to become a pro bodybuilder. Right now, Jared's ... […]
- Tragic plight of aspiring makeup artist, 25, suffering from cystic fibrosis is on her third and FINAL set of lungs on February 15, 2019 at 9:20 am
Tiffany Senter is just 25, but she has already had three sets of lungs. She was born with cystic fibrosis, a chronic genetic disease that causes sticky fluid to build up in several organs, including t... […]
via Bing News